Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery disease risk

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1035-1041

  Wang, Hairong ^a   Jiang, Mei ^a   Zhu, Hua ^a   Chen, Qihong ^b   Gong, Peihua ^a   Lin, Jie ^a   Lu, Jide ^a   Qiu, Jianping ^a  

^a Shanghai Pudong New Area Gongli Hospital   (China)

^b SHANGHAI XUHUI CENTRAL HOSPITAL   (China)

Author keywords

Coronary artery disease; Meta analysis; Myocardial infarction; Polymorphism; PSMA6

Indexed keywords

MESSENGER RNA;

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; PSMA6 GENE; SAMPLE SIZE;

CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEASOME ENDOPEPTIDASE COMPLEX; RISK FACTORS;

EID: 84878346667     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2146-2     Document Type: Article

References (28)

1. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M (2002) Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347:1916-1923
2. Broeckel U, Hengstenberg C, Mayer B et al (2002) A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat Genet 30:210-214
3. Topol EJ, Smith J, Plow EF, Wang QK (2006) Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Mol Genet 15:R117-R123
4. Libby P (2002) Atherosclerosis in inflammation. Nature 420:868-874
5. Herrmann J, Ciechanover A, Lerman LO, Lerman A (2004) The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. Cardiovasc Res 61:11-21
6. Meiners S, Laule M, Rother W et al (2002) Ubiquitin-proteasome pathway as a new target for the prevention of restenosis. Circulation 105:483-489
7. Elliott PJ, Zollner TM, Boehncke WH (2003) Proteasome inhibition: a new anti-inflammatory strategy. J Mol Med 8:235-245
8. Ozaki K, Sato H, Iida A et al (2006) A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population. Nat Genet 38:921-925
9. Holm K, Melum E, Franke A, Karlsen TH (2010) SNPexp - a web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11:600
10. International HapMap Consortium (2003) The International HapMap Project. Nature 426:789-796
11. Stranger BE, Forrest MS, Dunning M et al (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848-853
12. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
13. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
14. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253
15. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
16. Sjakste T, Poudziunas I, Ninio E et al (2007) SNPs of PSMA6 gene-investigation of possible association with myocardial infarction and type 2 diabetes mellitus. Genetika 43:553-559
17. Takashima N, Shioji K, Kokubo Y, Okayama A, Goto Y, Nonogi H, Iwai N (2007) Validation of the association between the gene encoding proteasome subunit alpha type 6 and myocardial infarction in a Japanese population. Circ J 71:495-498
18. Bennett DA, Xu P, Clarke R, Zondervan K, Parish S, Palmer A, Cardon L, Peto R, Lathrop M, Collins R (2008) The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6,946 cases and 2,720 controls from a United Kingdom population. Eur J Hum Genet 16:480-486
19. Barbieri M, Marfella R, Rizzo MR, Boccardi V, Siniscalchi M, Schiattarella C, Siciliano S, Lemme P, Paolisso G (2008) The -8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients. Atherosclerosis 201:117-123
20. Liu X, Wang X, Shen Y, Wu L, Ruan X, Lindpaintner K, Yusuf S, Engert JC, Anand S, Tan X, Liu L (2009) The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population. Atherosclerosis 206:199-203
21. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27:88-94
22. Alsmadi O, Muiya P, Khalak H, Al-Saud H, Meyer BF, Al-Mohanna F, Alshahid M, Dzimiri N (2009) Haplotypes encompassing the KIAA0391 and PSMA6 gene cluster confer a genetic link for myocardial infarction and coronary artery disease. Ann Hum Genet 73:475-483
23. Hinohara K, Nakajima T, Sasaoka T, Sawabe M, Lee BS, Ban J, Park JE, Izumi T, Kimura A (2009) Replication studies for the association of PSMA6 polymorphism with coronary artery disease in East Asian populations. J Hum Genet 54:248-251
24. Ikeda S, Tanaka N, Arai T, Chida K, Muramatsu M, Sawabe M (2012) Polymorphisms of LTA, LGALS2, and PSMA6 genes and coronary atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Atherosclerosis 221:458-460
25. Kozak M (1997) Recognition of AUG and Alternative Initiator Codos Is Augmented by G in Position +4 but is not Generally Affected by the Nucleotides in Position +5 and +6. EMBO J 16:2482-2492
26. Kozak M (2002) Pushing the limits of the scanning mechanism for initiation of translation. Gene 299:1-34
27. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426:895-899
28. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847